Office-Based Asthma Screening Intervention

Asthma Clinical Trial

Official title:

Office-Based Asthma Screening Intervention

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00156468
• Other study ID #: 10035
• Status: Completed
• Phase: N/A
• First received: September 8, 2005
• Last updated: May 11, 2011
• Start date: October 2003
• Est. completion date: September 2005

Study information

• Verified date: May 2011
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 365
• Est. completion date: September 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 2 Years to 12 Years

Eligibility

Inclusion Criteria:

• Children ages 2-12

• Children arriving for an office visit in two Rochester, NY pediatric clinics

• Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

• Children arriving at the office visit with an adult that is not their parent or guardian

• Children arriving at the office visit with a parent or guardian that does not speak English

• Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• Provider Prompt

Locations

Country	Name	City	State
United States	University of Rochester	Rochester	New York

Sponsors (3)

Lead Sponsor	Collaborator
University of Rochester	Halcyon Hill Foundation, Robert Wood Johnson Foundation

Country where clinical trial is conducted

United States, 

References & Publications (3)

Halterman JS, Fagnano M, Conn KM, Szilagyi PG. Do parents of urban children with persistent asthma ban smoking in their homes and cars? Ambul Pediatr. 2006 Mar-Apr;6(2):115-9. — View Citation

Halterman JS, Fisher S, Conn KM, Fagnano M, Lynch K, Marky A, Szilagyi PG. Improved preventive care for asthma: a randomized trial of clinician prompting in pediatric offices. Arch Pediatr Adolesc Med. 2006 Oct;160(10):1018-25. — View Citation

Halterman JS, Kitzman H, McMullen A, Lynch K, Fagnano M, Conn KM, Yoos HL. Quantifying preventive asthma care delivered at office visits: the Preventive Asthma Care-Composite Index (PAC-CI). J Asthma. 2006 Sep;43(7):559-64. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Secondary	Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.